Indeed, the enhanced activation of β-catenin/TCF transcriptional activity has been associated with accelerated HCC tumorigenesis in a number of recent studies [46–48], suggesting that targeting the direct interaction of β-catenin with TCF rather than targeting other Wnt/β-catenin signaling regulators might effectively target liver CSCs. Here, HNF4A is linked to hepatocellular carcinoma.